USD 3.26
(-36.2%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -10.27 Million USD | -114.0% |
2022 | -4.8 Million USD | -46.07% |
2021 | -3.28 Million USD | -1.52% |
2020 | -3.23 Million USD | 4.19% |
2019 | -3.38 Million USD | -5.03% |
2018 | -3.21 Million USD | -44.69% |
2017 | -2.22 Million USD | 0.0% |
2014 | -3.31 Million USD | 63.26% |
2013 | -9.02 Million USD | -119.9% |
2012 | -4.1 Million USD | 11.36% |
2011 | -4.63 Million USD | 41.59% |
2010 | -7.92 Million USD | -8.87% |
2009 | -7.28 Million USD | -3.95% |
2008 | -7 Million USD | -55.09% |
2007 | -4.51 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -7.48 Million USD | -146.13% |
2024 Q1 | -3.04 Million USD | 30.76% |
2023 FY | -10.27 Million USD | -114.0% |
2023 Q3 | -2.42 Million USD | -14.92% |
2023 Q4 | -4.39 Million USD | -81.33% |
2023 Q2 | -2.1 Million USD | -56.07% |
2023 Q1 | -1.35 Million USD | 11.49% |
2022 Q2 | -1.21 Million USD | -21.61% |
2022 Q1 | -996.55 Thousand USD | 26.3% |
2022 FY | -4.8 Million USD | -46.07% |
2022 Q4 | -1.52 Million USD | -43.04% |
2022 Q3 | -1.06 Million USD | 11.95% |
2021 Q2 | -540.93 Thousand USD | 16.15% |
2021 Q1 | -645.11 Thousand USD | 31.47% |
2021 FY | -3.28 Million USD | -1.52% |
2021 Q4 | -1.35 Million USD | -80.46% |
2021 Q3 | -749.29 Thousand USD | -38.52% |
2020 Q4 | -941.33 Thousand USD | -30.92% |
2020 Q2 | -833 Thousand USD | -11.81% |
2020 FY | -3.23 Million USD | 4.19% |
2020 Q1 | -745 Thousand USD | 36.27% |
2020 Q3 | -719 Thousand USD | 13.69% |
2019 Q1 | -712 Thousand USD | -12.13% |
2019 Q3 | -789 Thousand USD | -11.28% |
2019 Q4 | -1.16 Million USD | -48.16% |
2019 FY | -3.38 Million USD | -5.03% |
2019 Q2 | -709 Thousand USD | 0.42% |
2018 Q1 | -496 Thousand USD | 50.03% |
2018 Q4 | -635 Thousand USD | -12.39% |
2018 Q3 | -565 Thousand USD | 62.88% |
2018 Q2 | -1.52 Million USD | -206.85% |
2018 FY | -3.21 Million USD | -44.69% |
2017 Q4 | -992.5 Thousand USD | -86.91% |
2017 Q2 | -546 Thousand USD | 3.79% |
2017 Q1 | -567.5 Thousand USD | 0.0% |
2017 FY | -2.22 Million USD | 0.0% |
2017 Q3 | -531 Thousand USD | 2.75% |
2015 Q1 | -880.28 Thousand USD | -15.87% |
2014 FY | -3.31 Million USD | 63.26% |
2014 Q2 | -1.8 Million USD | -844.32% |
2014 Q1 | -190.75 Thousand USD | 72.07% |
2014 Q4 | -759.73 Thousand USD | 45.26% |
2014 Q3 | -1.38 Million USD | 22.95% |
2013 Q3 | -641.88 Thousand USD | 35.7% |
2013 Q4 | -683.03 Thousand USD | -6.41% |
2013 FY | -9.02 Million USD | -119.9% |
2013 Q1 | -7.02 Million USD | -1329.96% |
2013 Q2 | -998.21 Thousand USD | 85.79% |
2012 Q3 | -396.12 Thousand USD | 84.25% |
2012 Q4 | -491.22 Thousand USD | -24.01% |
2012 FY | -4.1 Million USD | 11.36% |
2012 Q1 | -558.82 Thousand USD | -0.81% |
2012 Q2 | -2.51 Million USD | -350.14% |
2011 Q3 | -476.53 Thousand USD | 73.77% |
2011 Q1 | -856.61 Thousand USD | -10.71% |
2011 Q4 | -554.35 Thousand USD | -16.33% |
2011 Q2 | -1.81 Million USD | -112.12% |
2011 FY | -4.63 Million USD | 41.59% |
2010 FY | -7.92 Million USD | -8.87% |
2010 Q2 | -4.33 Million USD | -299.49% |
2010 Q1 | -1.08 Million USD | -25.65% |
2010 Q4 | -773.76 Thousand USD | 34.64% |
2010 Q3 | -1.18 Million USD | 72.7% |
2009 Q4 | -863.85 Thousand USD | 63.04% |
2009 FY | -7.28 Million USD | -3.95% |
2009 Q3 | -2.33 Million USD | 43.44% |
2009 Q2 | -4.13 Million USD | -272.39% |
2009 Q1 | -1.1 Million USD | -18.93% |
2008 Q4 | -933.07 Thousand USD | 15.74% |
2008 Q3 | -1.1 Million USD | 65.0% |
2008 Q1 | -1.17 Million USD | 70.05% |
2008 Q2 | -3.16 Million USD | -168.41% |
2008 FY | -7 Million USD | -55.09% |
2007 Q2 | -2.13 Million USD | -143.6% |
2007 Q3 | -1.17 Million USD | 45.19% |
2007 FY | -4.51 Million USD | 0.0% |
2007 Q4 | -3.93 Million USD | -236.39% |
2007 Q1 | -876.38 Thousand USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Omnicell, Inc. | -34.86 Million USD | 70.527% |
Renalytix Plc | -29.6 Million USD | 65.291% |
Schrödinger, Inc. | -177.44 Million USD | 94.209% |
Simulations Plus, Inc. | 6.13 Million USD | 267.617% |
SOPHiA GENETICS SA | -74.82 Million USD | 86.266% |
Streamline Health Solutions, Inc. | -19.64 Million USD | 47.694% |
BrightSpring Health Services, Inc. Common Stock | 147.18 Million USD | 106.982% |
CareCloud, Inc. | -47.11 Million USD | 78.188% |
HealthEquity, Inc. | 128.13 Million USD | 108.02% |
Inovalon Holdings, Inc. | 71.71 Million USD | 114.331% |
Ontrak, Inc. | -20.67 Million USD | 50.295% |
Minerva Surgical, Inc. | -30.89 Million USD | 66.741% |
Nutex Health, Inc. | -31.77 Million USD | 67.657% |
OneMedNet Corporation | -8.37 Million USD | -22.717% |
Progyny, Inc. | 62.18 Million USD | 116.526% |
Augmedix, Inc. | -18.77 Million USD | 45.276% |
CareCloud, Inc. | -47.11 Million USD | 78.188% |
GE HealthCare Technologies Inc. | 2.43 Billion USD | 100.422% |
Sharecare, Inc. | -96.47 Million USD | 89.348% |
Aclarion, Inc. | -4.87 Million USD | -110.76% |
CareMax, Inc. | -656.15 Million USD | 98.434% |
Bullfrog AI Holdings, Inc. Common Stock | -5.36 Million USD | -91.459% |
Forian Inc. | -5.59 Million USD | -83.674% |
Bullfrog AI Holdings, Inc. Warrants | -5.36 Million USD | -91.459% |
HeartBeam, Inc. | -15.31 Million USD | 32.894% |
GeneDx Holdings Corp. | -163.66 Million USD | 93.721% |
SCWorx Corp. | -1.45 Million USD | -608.408% |
Definitive Healthcare Corp. | -329.8 Million USD | 96.884% |
10x Genomics, Inc. | -265.32 Million USD | 96.127% |
Zhongchao Inc. | -13.28 Million USD | 22.638% |
Accolade, Inc. | -114.45 Million USD | 91.021% |
MSP Recovery, Inc. | -559.87 Million USD | 98.164% |
R1 RCM Inc. | 147.9 Million USD | 106.948% |
Spok Holdings, Inc. | 21.22 Million USD | 148.411% |
Privia Health Group, Inc. | 20.64 Million USD | 149.768% |
EUDA Health Holdings Limited | -3.96 Million USD | -159.441% |
TruBridge, Inc. | -42.6 Million USD | 75.879% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 147.18 Million USD | 106.982% |
Sharecare, Inc. | -96.47 Million USD | 89.348% |
Health Catalyst, Inc. | -126.89 Million USD | 91.902% |
GoodRx Holdings, Inc. | -27 Million USD | 61.948% |
Premier, Inc. | 157.08 Million USD | 106.542% |
HealthStream, Inc. | 16.01 Million USD | 164.153% |
Certara, Inc. | -40.77 Million USD | 74.796% |
GeneDx Holdings Corp. | -163.66 Million USD | 93.721% |
Ontrak, Inc. | -20.67 Million USD | 50.295% |
SHL Telemedicine Ltd. | -9 Million USD | -14.108% |
CareCloud, Inc. | -47.11 Million USD | 78.188% |
EUDA Health Holdings Limited | -3.96 Million USD | -159.441% |
HeartBeam, Inc. | -15.31 Million USD | 32.894% |
Mangoceuticals, Inc. | -9.21 Million USD | -11.473% |
CareMax, Inc. | -656.15 Million USD | 98.434% |
Healthcare Triangle, Inc. | -11.34 Million USD | 9.441% |
National Research Corporation | 40.04 Million USD | 125.663% |
Aclarion, Inc. | -4.87 Million USD | -110.76% |
OptimizeRx Corporation | -26.4 Million USD | 61.076% |